Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States.
Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med. 2013 Jan 15; 158(2):84-92.